Tianjin Ringpu Bio-Technology Co.,Ltd. (SHE:300119)

SHE:300119 Revenue

Tianjin Ringpu Bio-Technology had revenue of 836.74M CNY in the quarter ending September 30, 2025, with 29.17% growth. This brings the company's revenue in the last twelve months to 3.55B, up 11.40% year-over-year. In the year 2024, Tianjin Ringpu Bio-Technology had annual revenue of 3.07B with 13.32% growth.

• Revenue (ttm): 3.55B
• Revenue Growth: +11.40%
• P/S Ratio: 2.67
• Revenue / Employee: 1.22M
• Employees: 2,900
• Market Cap: 9.48B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.07B	360.83M	13.32%
Dec 31, 2023	2.71B	624.85M	29.98%
Jan 1, 2023	2.08B	77.11M	3.84%
Jan 1, 2022	2.01B	6.73M	0.34%
Dec 31, 2020	2.00B	533.83M	36.40%